Dr. John Koreth, MD

Claim this profile

Dana Farber Cancer Institute

Studies Myelodysplastic Syndrome
Studies Acute Myelogenous Leukemia
2 reported clinical trials
8 drugs studied

Area of expertise

1

Myelodysplastic Syndrome

John Koreth, MD has run 2 trials for Myelodysplastic Syndrome. Some of their research focus areas include:

HLA-A positive
HLA-A negative
HLA positive
2

Acute Myelogenous Leukemia

John Koreth, MD has run 2 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:

HLA-A positive
HLA-A negative
HLA positive

Affiliated Hospitals

Image of trial facility.

Dana Farber Cancer Institute

Image of trial facility.

Brigham And Women's Hospital

Clinical Trials John Koreth, MD is currently running

More about John Koreth, MD

Clinical Trial Related

5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments John Koreth, MD has experience with

  • CD25hi Treg Depleted DLI
  • Ipilimumab
  • Cyclophosphamide
  • Fludarabine
  • Radiation
  • Thiotepa

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does John Koreth, MD specialize in?

Is John Koreth, MD currently recruiting for clinical trials?

Are there any treatments that John Koreth, MD has studied deeply?

What is the best way to schedule an appointment with John Koreth, MD?

What is the office address of John Koreth, MD?

Is there any support for travel costs?